Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs for tuberculosis.

C Grassi1

  • 1Institute of Respiratory Disease, University of Pavia, IRCCS S. Matteo Hospital, Via Taramelli, 5, 271 00 Pavia, Italy.

Expert Opinion on Investigational Drugs
|July 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventral striatal neuroimmune signalling biases the expression of social memory in male mice.

Brain, behavior, and immunity·2026
Same author

HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles.

mBio·2024
Same author

Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.

Endocrine·2020
Same author

Neural functional correlates of emotional processing in patients with first-episode psychoses: an activation likelihood estimation (ALE) meta-analysis.

Archives italiennes de biologie·2018
Same author

Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells.

Free radical biology & medicine·2016
Same author

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.

Scientific reports·2016
Same journal

Advancements in longevity pharmacology research - are we finally seeing clinical progression?

Expert opinion on investigational drugs·2026
Same journal

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026
Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026
Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026
Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026
Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026
See all related articles

Tuberculosis (TB) is resurging in industrialized nations due to HIV and immigration. Multidrug-resistant TB necessitates novel drugs and vaccines, as current treatments are failing.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Tuberculosis (TB) has seen an unexpected resurgence in industrialized countries over the past decade.
  • Contributing factors include the spread of Human Immunodeficiency Virus (HIV) infection and increasing immigration.
  • Emerging multidrug-resistant (MDR) strains of Mycobacterium tuberculosis are rendering existing therapies largely ineffective.

Purpose of the Study:

  • To address the growing challenge of multidrug-resistant tuberculosis (MDR-TB).
  • To explore alternative therapeutic strategies and the need for new drug development.
  • To highlight the requirement for more specific vaccines against tuberculosis.

Main Methods:

  • Review of current therapeutic regimens for tuberculosis.

Related Experiment Videos

  • Evaluation of in vitro antituberculosis activity of antimicrobials marketed for other infections.
  • Analysis of factors contributing to the resurgence of TB and MDR-TB.

    • Main Results:

    • Current therapies are becoming increasingly ineffective against MDR-TB strains.
    • Addition of certain antimicrobials (e.g., quinolones, oxacillin-clavulanic acid) to existing regimens is being explored.
    • There is an urgent need for new drugs targeting novel pathways and more effective vaccines.

    Conclusions:

    • The resurgence of TB and the rise of MDR-TB pose a significant public health threat.
    • Novel therapeutic agents and improved vaccines are critically needed to combat resistant tuberculosis strains.
    • Innovative approaches are required to circumvent the limitations of current tuberculosis treatments.